By InvitationNot Applicable

Global Utilization And Registry Database for Improved preservAtion of doNor Livers

United States1,000 participantsStarted 2022-03-15

Plain-language summary

The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor liver that were preserved and transported within the LIVERguard system, as well as retrospective standard of care patients

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Donor and donor liver matched to the recipient based upon institutional medical practice * Registered male or female primary liver transplant candidates Exclusion Criteria: * Donor and donor liver that do not meet institutional clinical requirements for transplantation * Living donors * Pediatric recipients (under 18)

What they're measuring

Graft Failure

Timeframe: Post-transplant through 1 year post

Early allograft dysfunction

Timeframe: 7 days post transplant

Rejection

Timeframe: Post-transplant through 1 year post

Primary Non-function

Timeframe: Post transplant to 7 days post-transplant

Survival

Timeframe: Transplant through 1 year post-transplant

Length of Stay

Timeframe: 1 year

Length of ICU stay

Timeframe: 1 year

Trial details

NCT IDNCT05082077

SponsorParagonix Technologies

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2027-08

View on ClinicalTrials.gov More Liver Diseases trials